Adalimumab-afzb Injection — FDA Drug Shortage

No longer listed by FDA — Pfizer Inc.

The FDA lists a drug shortage record for Adalimumab-afzb Injection (injection) from Pfizer Inc. with status No longer listed by FDA. The shortage was first posted on Oct 9, 2025.

Shortage details

Status
No longer listed by FDA
Company
Pfizer Inc.
Package NDC
0025-0325-01
Dosage Form
Injection
Presentation
Abrilada, Injection, Kit (NDC 0025-0325-01)
Initial Posting
Oct 9, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.